quinazolines has been researched along with Fungal Diseases in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antypenko, LM; Fedyunina, NS; Karpenko, OV; Katsev, AM; Kovalenko, SI; Novikov, VP | 1 |
| Babu, R; Guda, R; Kasula, M; Kumar, G; Lingabathula, H; Muthadi, S; Narsimha, S; Palabindela, R; Yellu, NR | 1 |
| Goldani, LZ; Pasqualotto, AC; Thiele, KO | 1 |
| Sheng, CQ; Wang, SZ; Zhang, WN | 1 |
| Denning, DW; Pasqualotto, AC | 1 |
| McCormack, JJ | 1 |
4 review(s) available for quinazolines and Fungal Diseases
| Article | Year |
|---|---|
Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole.
Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Quinazolines; Thiazoles; Triazoles | 2010 |
[Recent advances in the study of new antifungal lead compounds].
Topics: Antifungal Agents; Fungi; Heterocyclic Compounds; Humans; Lipopeptides; Molecular Structure; Mycoses; Nitriles; Plant Extracts; Plants, Medicinal; Pyridines; Quinazolines; Quinones; Structure-Activity Relationship; Thiazoles; Triazoles | 2010 |
New and emerging treatments for fungal infections.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Mycoses; Quinazolines; Stereoisomerism; Triazoles | 2008 |
Dihydrofolate reductase inhibitors as potential drugs.
Topics: Aminopterin; Animals; Antimalarials; Bacterial Infections; Biological Transport; Drug Interactions; Folic Acid; Folic Acid Antagonists; Helminthiasis; Humans; Immunosuppressive Agents; Leukemia, Experimental; Liver; Methotrexate; Mice; Mycoses; Neoplasms; Protozoan Infections; Psoriasis; Quinazolines; Rats; Receptors, Drug; Trypanosoma cruzi | 1981 |
2 other study(ies) available for quinazolines and Fungal Diseases
| Article | Year |
|---|---|
1-R-2-([1,2,4]Triazolo[1,5-c]quinazoline-2-ylthio)etanon(ol)s: Synthesis, Bioluminescence Inhibition, Molecular Docking Studies, Antibacterial and Antifungal Activities.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Fungi; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycoses; Quinazolines; Tetrahydrofolate Dehydrogenase; Triazoles | 2016 |
Novel substituted hydrazono indolo[2,1-b]quinazoline-6,12-dione analogues as cytostatic agents: Synthesis, crystal structure, biological evaluation and molecular docking studies.
Topics: A549 Cells; Anti-Infective Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Fungi; HEK293 Cells; HeLa Cells; Humans; Hydrazones; Indoleamine-Pyrrole 2,3,-Dioxygenase; MCF-7 Cells; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycoses; Quinazolines; Structure-Activity Relationship | 2016 |